Breast Cancer in Young Women 2020
DOI: 10.1007/978-3-030-24762-1_12
|View full text |Cite
|
Sign up to set email alerts
|

Management of Advanced Breast Cancer in Young Women: What’s New in Systemic Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 82 publications
0
1
0
Order By: Relevance
“…C. The risks for the foetus are intrauterine foetal retardation, preterm delivery, immaturity, neonatal toxicity -suppression of the bone marrow. This is the reason to recommend a minimum 3-weeks interval between chemotherapy and the expected time of delivery [15][16][17][18]. It is thus not routinely recommended to give chemotherapy after the 35 th g.w.…”
Section: Principles Of Chemotherapy During Pregnancymentioning
confidence: 99%
“…C. The risks for the foetus are intrauterine foetal retardation, preterm delivery, immaturity, neonatal toxicity -suppression of the bone marrow. This is the reason to recommend a minimum 3-weeks interval between chemotherapy and the expected time of delivery [15][16][17][18]. It is thus not routinely recommended to give chemotherapy after the 35 th g.w.…”
Section: Principles Of Chemotherapy During Pregnancymentioning
confidence: 99%